University of Southampton (US)
The University of Southampton (US) has been ranked as one of the top 100 Universities in the world (2013 QS World University Rankings). It has more than 17,000 undergraduate students and 7,000 postgraduates from over 130 different countries.
US has a successful track record of industrial collaborations and is at the centre of a cluster of local high technology companies. It has an enviable track record in the generation of patentable work, with a portfolio of over 350 patents. Southampton has a strong track record of working in European projects, especially within the Framework Programme. The Faculty of Medicine (FoM) is a leading centre of medical research in the UK. FoM’s strengths are immunology, cancer sciences, respiratory medicine, primary care and human development.
The main tasks that will be conducted at the University of Southampton within the scope of the PERISCOPE project will be the development of the human challenge model of Bordetella pertussis colonisation, and vaccine response studies in the 18-25 age group.
Professor Robert Read is a clinical investigator with 25 years of research experience in infection-related problems. His work has both depth and breadth, ranging across human challenge, clinical trials of vaccines and therapeutics, cellular microbiology, immunology and molecular genetics, but with a common theme of the study of the causes and prevention of severe infectious disease. He leads the Academic Unit of Clinical and Experimental Sciences at the University of Southampton and is Professor of Infectious Disease and Honorary Consultant Physician to the University Hospital Southampton.